CoC says parent firm has no assets other than holding in Orchid Pharma, which itself is undergoing CIRP; Even if there is a resolution for Orchid Pharma, nothing would be left for investors
Investors should also look at expense ratio, portfolio quality and track record
In most versions of the VIP strategy, the SIP amount will be varied depending on an objective parameter such as returns obtained
However, an issue arises when the broker decides to remove an existing stock or introduce a new one into the basket